Hernandez L D, White J M
Department of Biochemistry, University of California, San Francisco 94143, USA.
J Virol. 1998 Apr;72(4):3259-67. doi: 10.1128/JVI.72.4.3259-3267.1998.
The transmembrane subunit (TM) of the avian leukosis and sarcoma virus (ALSV) envelope glycoprotein (Env) contains a stretch of conserved hydrophobic amino acids internal to its amino terminus (residues 21 to 42). By analogy with similar sequences in other viral envelope glycoproteins, this region has been proposed to be a fusion peptide. We investigated the role of this region by changing each of three hydrophobic residues (Ile-21, Val-30, and Ile-39) to glutamatic acid and lysine in the ALSV subgroup A Env. Like wild-type (wt) Env, all six mutant Env proteins were proteolytically processed, oligomerized, and expressed at the cell surface in a form that bound Tva, the ALSV subgroup A receptor. Like wt Env, Ile21Glu, Ile21Lys, Va30Glu, and Val30Lys changed conformation upon binding Tva, as assayed by sensitivity to thermolysin. Ile39Glu and Ile39Lys were cleaved by thermolysin in both the absence and presence of Tva. Although incorporated into virus particles at approximately equal levels, all mutant Envs were compromised in their ability to support infection. The mutants at residues 21 and 30 showed levels of infection 2 to 3 orders of magnitude lower than that of wt Env. The mutants at residue 39 were noninfectious. Furthermore, none of the mutants displayed activity in a cell-cell fusion assay. Our results support the contention that residues 21 to 42 of ALSV subgroup A Env constitute its fusion peptide.
禽白血病和肉瘤病毒(ALSV)包膜糖蛋白(Env)的跨膜亚基(TM)在其氨基末端内部(第21至42位氨基酸残基)含有一段保守的疏水氨基酸序列。通过与其他病毒包膜糖蛋白中的类似序列进行类比,该区域被认为是一个融合肽。我们通过将ALSV A亚组Env中的三个疏水残基(Ile-21、Val-30和Ile-39)分别替换为谷氨酸和赖氨酸来研究该区域的作用。与野生型(wt)Env一样,所有六种突变型Env蛋白都经过蛋白水解加工、寡聚化,并以结合ALSV A亚组受体Tva的形式在细胞表面表达。与wt Env一样,通过嗜热菌蛋白酶敏感性测定,Ile21Glu、Ile21Lys、Va30Glu和Val30Lys在结合Tva时会发生构象变化。Ile39Glu和Ile39Lys在有无Tva的情况下都能被嗜热菌蛋白酶切割。尽管突变型Env以大致相同的水平掺入病毒颗粒中,但它们支持感染的能力都受到了损害。第21和30位残基处的突变体感染水平比wt Env低2至3个数量级。第39位残基处的突变体无感染性。此外,没有一个突变体在细胞-细胞融合试验中表现出活性。我们的结果支持这样的观点,即ALSV A亚组Env的第21至42位残基构成其融合肽。